Cargando…
Eosinophilia as a treatable trait in three patients with asthma and COPD
The combination of asthma and chronic obstructive pulmonary disease (COPD) in an individual can present significant challenges to achieving satisfactory outcomes. More recently, the concepts of precision medicine and treatable traits have arisen as promising tools to improve care for this group. In...
Autores principales: | Ramsahai, James Michael, Simpson, Jodie, Wark, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961508/ https://www.ncbi.nlm.nih.gov/pubmed/29796275 http://dx.doi.org/10.1002/rcr2.295 |
Ejemplares similares
-
Mepolizumab asthma treatment failure due to refractory airway eosinophilia, which responded to benralizumab
por: Cook, Alistair, et al.
Publicado: (2021) -
Asthma, COPD & ACOS: -Omics Approach to Refine Treatable Traits in These Conditions
por: CHUNG, Kian Fan
Publicado: (2017) -
Genomics of Treatable Traits in Asthma
por: Espuela-Ortiz, Antonio, et al.
Publicado: (2023) -
A survey of specialist opinions on biomarker use in severe asthma in Australia: scepticism but hope?
por: Ramsahai, J. Michael, et al.
Publicado: (2020) -
Treatable Traits in COPD – A Proposed Approach
por: Cardoso, João, et al.
Publicado: (2021)